ArticleInternational journal of clinical pharmacy2023

Analysis of the association between Janus kinase inhibitors and malignant skin tumors using the Food and Drug Administration Adverse Event Reporting System.

Tianqi Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.